Will the 'Unvaxxed' Have the Last Laugh? For over a year

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
344
Will the 'Unvaxxed' Have the Last Laugh?

For over a year now, the messaging from our “health experts” and government leaders has been as dreary as it has been monotonal: Take the covid “vaccine” or die.

That talking point was reiterated by President Biden* just a few weeks ago when he warned the “unvaxxed” would face “a winter of severe disease and death.” And that was before New Jersey’s resident rodent meteorologist, Milltown Mel, shuffled off this mortal coil just prior to Groundhog Day. So I guess that means, in New Jersey at least, another six weeks of severe disease and death.

Originally, of course, we were told the mRNA injections would prevent people from contracting the disease. “If you get vaccinated, you won’t get covid” was the mantra recited for months, in various forms and multiple forums, by Drs. Fauci, Walensky, and Murthy, President Biden*, and many others. We were also assured that sufficiently jabbed people don’t spread the virus, with Fauci claiming the injections constitute a “dead end for covid.”

It's important not to forget those statements, as the same people now insist they never promised any such thing. Perhaps that’s because, in the face of overwhelming evidence, they’ve been forced to admit jabbed people can and do get covid and can and do give it to others. Said Walensky just a few weeks ago, “what [the vaccines] can’t do anymore is prevent transmission.” Even Pfizer CEO Albert Bourla was forced to acknowledge that his products now offer “limited, in any, protection.”

But what about the vaunted “death benefit” from the mRNA injections? They still protect against serious illness and death, right? Well, yes, that does seem to be the case—but the effect is waning fast. Moreover, the claim itself comes with several asterisks.

There have always been questions about how we count “covid deaths,” as both the CDC and the UK’s National Health Service have recently acknowledged. But if anything, those problems have been amplified in the way we differentiate between “vaccinated” and “unvaccinated” deaths.

For one thing, the most commonly cited number to prove “vaccine efficacy”—“90 percent of covid deaths are among the unvaccinated”—is fundamentally flawed because it goes back to the earliest days of the injections when almost no one had gotten them. Obviously, nearly all who died of (or with) covid in January and February of 2021 were “unvaccinated.”

Moreover, our health officials have been engaged for over a year in a kind of statistical sleight of hand, categorizing people who have taken the injections as “unvaccinated” up until 14 days after their second shot, which means at least five or six weeks have passed since their first shot. In doing so, they ignore evidence that the shots actually make people more susceptible to the virus in the short term. So if you contract covid after getting both shots, but prior to the closing of the 14-day window, and then die, you are considered an “unvaccinated” death. (They’re playing this same trick with the booster shots, too.)

This method also does not account for those who die as a result of immediate adverse reactions to the shots. Such deaths are generally numbered among the “unvaccinated,” even though it was the “vaccine” that killed them. But that’s a topic for another day.

Another fact the Covidians like to conveniently gloss over is that most people who die from covid, still, are elderly and/or infirm. In many cases, they’re already at death’s door, too sick even to be injected, which for them would simply hasten the inevitable with no appreciable benefit. Yet when they do die, they’re chalked up as “unvaccinated.” That clearly skews the numbers.

Unfortunately for the vaccinators, the “death benefit” narrative is beginning to erode, much like the “you won’t get covid” narrative before it. The latest statistics out of the UK (whose numbers are more accurate and honest than ours, although still not completely transparent), as broken down by Igor Chudov on Substack, show protection against death waning in all age groups, week over week, by an average of seven percent. Worst is the 40-49 age group, which just saw a 12 percent decline.

In addition, the director of the coronavirus ward at Israel’s Ichilov Hospital, Prof. Jacob Giris, reports that at his institution, “between 70 and 80 percent of…severe cases are vaccinated” and boosted, with “at least three injections.”

He goes on to conclude, in an interview with a local news channel, that “the vaccine has no significance regarding severe illness.”


And then there’s this: a new study out of The Netherlands claims to have determined the reason for the apparent “death benefit”—and it’s not good news. As you may recall, way back at the beginning of the pandemic, we were told it's often not the coronavirus itself that kills but rather the immune system’s extreme overreaction to the virus—the “cytokine storm.” Remember that?


Well, the Dutch researchers think they know why the injections seem to prevent some deaths: because they impede the immune system’s response to the point where such extreme reactions are less likely. From the study: “We observed a significant reduction in the production of IFN-a (Interferon-alpha, a primary cytokine) secreted after…the administration of the second dose of the vaccine. This may hamper the initial innate immune response against the virus.”

So, yeah. There you go. The injections might—emphasis on might—provide some short-term protection against serious illness and death, although that benefit appears to be disappearing fast. But at what cost? The potentially permanent suppression of your immune system?


https://townhall.com/columnists/robjenkins/20...PPKJHDQMcY
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CIC Services Unleashes PortfolioVantage for Property Owners

Updated Category News Views 3

Eyeing Profit in Tenant Liability Insurance CIC Services has cooked up something intriguing for property owners: a shot at fatter profits through their PortfolioVantage program. Launching now, this tenant legal liability strategy promises more than just basic tenant coverage—it's a potential financial boon for savvy landlords willing to dive in. The Gist of...

Continue Reading
Acer's New Monitors: ePaper, Triple Displays & More

Updated Category News Views 6

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

Continue Reading
CME Group Unveils 23rd University Trading Challenge

Updated Category News Views 3

An Invitation to Aspiring Traders Around the Globe In the land of trading, where fortunes rise and fall quicker than you can click a mouse, CME Group is setting the stage for the next batch of financial wizards. This year marks the 23rd round of their University Trading Challenge, a veritable boot camp for young aspirants looking to hone their skills in the high-stakes...

Continue Reading
Evotec and Plectonic Join Forces on Tumor Immunotherapy

Updated Category News Views 4

Collaboration Spotlight: A New Horizon for Tumor Treatments Ever wonder why curing solid tumors has been such a tough nut to crack? Evotec SE (NASDAQ: EVO) and Plectonic Biotech are wagering that their collaboration might just hold the key to unlocking new answers. They’re pooling their cutting-edge tech to take a fresh swing at this stubborn problem. Here’s what’s...

Continue Reading
Father's Bone Marrow Gift Transforms Daughter's Future

Updated Category News Views 1

When Hope Hinges on a Medical Miracle In a world of high-stakes trades and volatile markets, you'd think that there isn't room for stories like this. But life throws curveballs, some more daunting than what you'll find on Wall Street. Take the case of Victoria, a toddler who beat the odds thanks to a groundbreaking bone marrow transplant at Nicklaus Children's Hospital in...

Continue Reading
Robo.ai Surpasses $180 Million in Q2 Revenue Surge

Updated Category News Views 5

Robo.ai's Financial Rocket Lift-off: Q2 Highlights Who would've thought a single acquisition could propel a company's revenue north of $180 million in just three months? Well, Robo.ai, with its recent grab of Quantum Core Capital (QC Capital), shattered that ceiling, showcasing what a savvy acquisition and a dash of tech wizardry can achieve. Strong Quarter, Stronger...

Continue Reading
REMAX Welcomes Alex Vidal as President Amid Realignment

Updated Category News Views 4

Step aside and pay attention, folks—there's a new player in town. REMAX has just roped in Alex Vidal as their new President. Now, Vidal isn't some rookie fresh out of real estate school. This guy has logged almost three decades in the trenches, wielding his fair share of influence across various facets of the industry. Trust me, when a company of REMAX's caliber snaps...

Continue Reading
Smart Buying in Hilton Head: Second-Home Key Insights

Updated Category News Views 1

Choosing Your Slice of Paradise in Hilton Head Picture this—not just a sandy paradise for vacationing, but a hotspot for second-home buyers weighing their options like they're sizing up their next big investment. Enter Hilton Head, S.C., a place where strategic move means scooping up properties that marry lifestyle with fiscal savvy. Sizing Up the Dream: More Than Just...

Continue Reading
ZERO Fresh Start: RAVEN2's New Era Begins Sept 15

Updated Category News Views 2

What's the Big Deal with ZERO? Alright, so here we go, folks—Netmarble's strapping in with their latest server for RAVEN2, and it's called ZERO. Ever heard of fresh starts? ZERO is exactly that. This isn't your usual server shuffle. Lads and ladies who've felt the grind’ll tell you, ZERO's introducing a slew of changes you might want to sit up for. Pre-registration's...

Continue Reading
Hyperscale Recalibrates: AI Boom or Risky Bet?

Updated Category News Views 0

Is Hyperscale Making the Right Move? Hyperscale Data, Inc. waved goodbye to the Bitcoin mining days to clear the stage for artificial intelligence (AI). But is this strategic leap off the blockchain and into AI territory as golden as promised? Whisper around the street is it could turn into a $3 billion windfall. But let's chew through the details before toasting...

Continue Reading

Top 5 Most Recently Viewed Articles

Olympus Announces New CPT Codes for iTind Procedure

Updated Category News Views 244

Final Category I CPT Codes and Reimbursement Rates Introduced Olympus Corporation, a leading global medical technology firm, is excited to report that the Centers for Medicare and Medicaid Services (CMS) have finalized the Category I Current Procedural Terminology (CPT) codes and reimbursement rates for the iTind procedure. This announcement marks a significant milestone...

Continue Reading
Stax Music Academy Honors Legacy Through 25-Year Journey

Updated Category News Views 489

Celebrating 25 Years of Stax Music Academy Stax Music Academy (SMA) proudly marks its 25th anniversary by enhancing the legacy of soul music through education and outreach. As part of this significant milestone, SMA has launched Soul of America, an annual virtual performance production, complete with a study guide aimed at educators and students alike. Engaging...

Continue Reading
Exploring the LED Driver IC Market's Rise and Future Trends

Updated Category News Views 212

Understanding the LED Driver IC Market Growth The LED Driver Integrated Circuit (IC) market is on a remarkable upward trajectory, with projections indicating it will grow from USD 3.79 billion in 2023 to an impressive USD 16.05 billion by 2032. This anticipated growth represents a robust compound annual growth rate (CAGR) of 17.46% between 2024 and 2032. The surge in...

Continue Reading
Warehouse REIT Plc Public Disclosure: Key Insights and Details

Updated Category News Views 107

Understanding Public Disclosures by Warehouse REIT Plc The public disclosure made by Warehouse REIT Plc provides critical information for investors and stakeholders deeply interested in the functioning of the company. These disclosures are pivotal for transparency, especially when it comes to positions held in relevant securities that represent significant ownership...

Continue Reading
ARGAN Shares: Voting Rights and Financial Outlook in 2025

Updated Category News Views 255

Understanding ARGAN's Voting Rights and Share Capital On an important date in February, ARGAN provided crucial insights into its voting rights and total shares as part of its commitment to transparency and shareholder engagement. This information is especially relevant ahead of their upcoming Combined General Meeting of Shareholders. Voting Rights and Share Capital...

Continue Reading